Health and Fitness Health and Fitness
Mon, July 20, 2009
[ Mon, Jul 20th 2009 ] - Market Wire
San West, Inc.: San West, Inc. Announces 35% Increase in Buggy World Service and Repair Revenue
[ Mon, Jul 20th 2009 ] - Market Wire
Eurand N.V.: Eurand Successfully Completes Regist .. acetamol ODT 250 and 500 mg in the European Union
[ Mon, Jul 20th 2009 ] - Market Wire
SemBioSys announces non-binding letter of intent .. h Avrio Ventures Limited Partnership and Botaneco
[ Mon, Jul 20th 2009 ] - Market Wire
Reflect Scientific: Reflect Scientific Receives $900,000 Long-Term U.S. Government Contract
Sun, July 19, 2009
[ Sun, Jul 19th 2009 ] - Market Wire
Human Genome Sciences, Inc.: Human Genome Science .. e Positive Phase 3 Study Results for BENLYSTA(TM)
Fri, July 17, 2009
[ Fri, Jul 17th 2009 ] - Market Wire
BioMS Medical announces second quarter 2009 results
[ Fri, Jul 17th 2009 ] - Market Wire
Atlantis Systems Corp.: Atlantis Reports-TSX Anno .. ces De-Listing of Stock Effective August 11, 2009
[ Fri, Jul 17th 2009 ] - Market Wire
The GPS Tracking Network: AGRI-DYNAMICS, Inc. Cre .. ellow Cab of Dallas, Adds as GPS Tracking Custome
[ Fri, Jul 17th 2009 ] - Market Wire
Big Stick Media Corporation: Big Stick Media Corp .. ancial Results for the Quarter Ended May 31, 2009
[ Fri, Jul 17th 2009 ] - Market Wire
PharmaGap Provides Guidance on Cancer Drug Testing Timetable
[ Fri, Jul 17th 2009 ] - Market Wire
Electro-Optical Sciences, Inc.: Electro-Optical S .. Announces $15 Million Registered Direct Offering
[ Fri, Jul 17th 2009 ] - Market Wire
Econiche(TM) Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease
Thu, July 16, 2009
[ Thu, Jul 16th 2009 ] - Market Wire
VIVIMIND(TM) granted certificate of free sale as .. Italy - Premarket notification filed in the U.S.
[ Thu, Jul 16th 2009 ] - Market Wire
iCo Therapeutics Closes Non-Brokered Private Placement
[ Thu, Jul 16th 2009 ] - Market Wire
Metro One Development, Inc. and Imagin8: Metro On .. evelopment of a Portable Interactive Floor System
[ Thu, Jul 16th 2009 ] - Market Wire
Angiotech Pharmaceuticals announces FDA approval of TAXUS(R) Liberte(R) Long Stent
[ Thu, Jul 16th 2009 ] - Market Wire
HearUSA, Inc.: HearUSA Sets Second Quarter 2009 C .. ference Call for Tuesday, August 11 at 4:30 PM ET
[ Thu, Jul 16th 2009 ] - Market Wire
Atrium Innovations to Hold 2009 Second Quarter Fi .. esults Conference Call and Webcast on August 12th
[ Thu, Jul 16th 2009 ] - Market Wire
Orex Minerals Inc.: Orex Signs Letter of Intent t .. s in Coneto Silver-Gold Mining Camp in Durango Me
[ Thu, Jul 16th 2009 ] - Market Wire
MedaSorb Technologies Corporation: MedaSorb and C .. nterviews by The Wall Street Transcript and CEO-C
[ Thu, Jul 16th 2009 ] - Market Wire
San West, Inc.: San West, Inc. Opens New Buggy World Retail Location
[ Thu, Jul 16th 2009 ] - Market Wire
PharmaGap Raises Additional Equity Financing
[ Thu, Jul 16th 2009 ] - Market Wire
Adeona Pharmaceuticals, Inc.: Adeona Presents Res .. 9 International Conference on Alzheimer's Disease
[ Thu, Jul 16th 2009 ] - Market Wire
Oncolytics Biotech(R) Inc. Announces Publication .. ic Activity of Reovirus and Chemotherapy in NSCLC
[ Thu, Jul 16th 2009 ] - Market Wire
Indie Ranch Media, Inc.: Indie Ranch Media Subsid .. unces Further Developments on NetMix Broadcasting
Wed, July 15, 2009
[ Wed, Jul 15th 2009 ] - Market Wire
Basilea Pharmaceutica AG: NICE issues positive Fi .. ination recommending the use of Basilea's Toctino
[ Wed, Jul 15th 2009 ] - Market Wire
ALDA Pharmaceuticals Corp.: ALDA Pharmaceuticals .. Named Official Supplier for the 2010 Winter Games
[ Wed, Jul 15th 2009 ] - Market Wire
Given Imaging: Multi-Center Study on First-Genera .. OLON Published in New England Journal of Medicine
[ Wed, Jul 15th 2009 ] - Market Wire
BELLUS Health Inc. Announces Record Date for $12 Million Rights Offering To Common Shareholders
[ Wed, Jul 15th 2009 ] - Market Wire
The Medicines Company: The Medicines Company to A .. 009 Financial Results on Wednesday, July 29, 2009

The Medicines Company: The Medicines Company to Announce Second Quarter 2009 Financial Results on Wednesday, July 29, 2009


Published on 2009-07-15 13:38:58, Last Modified on 2009-07-15 13:39:04 - Market Wire
  Print publication without navigation


PARSIPPANY, NJ--(Marketwire - July 15, 2009) - The Medicines Company (NASDAQ: [ MDCO ]) has scheduled its quarterly conference call for Wednesday, July 29, 2009 at 8:30 a.m. Eastern Time to discuss second quarter 2009 financial results and operational developments.

The conference call will be available via phone and webcast. The dial in information is listed below: 

 Domestic Dial In: 800-884-5695 International Dial In: 617-786-2960 Passcode for both dial in numbers: 64853162

Replay is available from 11:30 a.m. Eastern Time following the conference call through August 12, 2009. To hear a replay of the call, dial 888-286-8010 (domestic) and 617-801-6888 (international). Passcode for both dial in numbers is 37428278.

This call is being webcast and can be accessed at The Medicines Company website at [ www.themedicinescompany.com ].

About The Medicines Company

The Medicines Company (NASDAQ: [ MDCO ]) is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. The Company markets Angiomax® (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, and Cleviprex® (clevidipine butyrate) injectable emulsion in the United States for the reduction of blood pressure when oral therapy is not feasible or not desirable. The Company also has two products in late stage development, cangrelor, an investigational antiplatelet agent, and oritavancin, a semi-synthetic lipoglycopeptide antibiotic currently awaiting EU regulatory approval. The Company's pipeline also includes a serine protease inhibitor, CU2010, in early-stage development. The Medicines Company's website is [ www.themedicinescompany.com ].

Contributing Sources